NHI.no
Annonse
Informasjon

Råd ved SLE og graviditet

Systemisk lupus erytematosus kan forverres under en graviditet. Gitt at sykdommen er i god fase og at du overvåkes nøye gjennom hele svangerskapet, kan graviditet likevel gjennomføres.

Kvinner med SLE bør planlegge et eventuelt svangerskap godt.

Sist oppdatert:

23. apr. 2024

Dette dokumentet er basert på det profesjonelle dokumentet Systemisk lupus erytematosus . Referanselisten for dette dokumentet vises nedenfor

  1. Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81-ITC96. PMID: 32479157 PubMed
  2. Vaillant AAJ, Goyal A, Varacallo M. Systemic Lupus Erythematosus. StatPearls (Internet). Last Update: February 27, 2023. www.ncbi.nlm.nih.gov
  3. Tunnicliffe DJ, Palmer SC, Henderson L, et al. Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD002922. The Cochrane Library
  4. Lerang K, Gilboe I, Garen T, et al. High incidence and prevalence of systemic lupus erythematosus in Norway. Lupus 2012; 21: 1362-9. pmid:22914817 PubMed
  5. Ingvarsson RF, Bengtsson AA, Jönsen A. Variations in the epidemiology of systemic lupus erythematosus in southern Sweden. Lupus. 2016 Jun;25(7):772-80. Epub 2016 Feb 27. PMID: 26923282. pubmed.ncbi.nlm.nih.gov
  6. Laustrup H, Voss A, Green A, Junker P. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol. 2009 Mar-Apr;38(2):128-32. PMID: 19117248. pubmed.ncbi.nlm.nih.gov
  7. Massias JS, Smith EMD, Al-Abadi E, et al.Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus. 2020 Apr;29(5):474-481.Epub 2020 Mar 31. PMID: 32233733. pubmed.ncbi.nlm.nih.gov
  8. Groot N, Graeff N, Avcin T, et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 2017. pmid:28630236 PubMed
  9. Moser, KL, Kelly, JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009; 10: 373-9. doi:10.1038/gene.2009.39 DOI
  10. Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev 2009; 8: 456-61. pmid:19167524 PubMed
  11. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019; 78:1151. PubMed
  12. Aringer M, Brinks R, Dörner T, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis 2021. pmid:33568386 PubMed
  13. Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011 Jun. 164(6):1335-41. pmid: 21574972 PubMed
  14. Rubin RL. Drug-induced lupus. Expert Opin Drug Saf 2015; 14: 361-78. pmid:25554102 PubMed
  15. Gluhovschi C, Gluhovschi G, Petrica L, et al. Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma. J Immunol Res 2015. pmid:26090485 PubMed
  16. Vu Lam N-C, Ghetu MV, Bieniek ML. Systemic lupus erythematosus: Primary care approach to diagnosis and management. Am Fam Physician 2016; 94: 284-94. American Family Physician
  17. Kivity S, Agmon-Levin N, Zandman-Goddard G et al. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med 2015; 13: 43. pmid:25858312 PubMed
  18. Joseph FG, Scolding NJ. Neurolupus. Pract Neurol 2010; 10: 4-15. pmid:20130291 PubMed
  19. Marite Rygg og Berit Flatø: Generell veileder i pediatri: Systemiske bindevevssykdommer, sist oppdatert 01.01.2018, siden lest 26.03.24 www.helsebiblioteket.no
  20. Skorpen CG, Salvesen KÅB, Palm Ø, Radtke M, Wallenius M. Svangerskapskomplikasjoner hos kvinner med systemisk lupus erythematosus. Tidsskr Nor Legeforen 2021; 141: 758-60. pmid:34047174 PubMed
  21. Nasjonal kompetansetjeneste for svangerskap og revmatiske sykdommer (NKSR). Nasjonal veileder for svangerskap og revmatiske sykdommer. Trondheim; sist oppdatert mars 2018, siden besøkt 13.09.2018
  22. Skorpen CG, Lydersen S, Gilboe IM et al. Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study. Ann Rheum Dis 2018; 77: 264-69. pmid:29092851 PubMed
  23. Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol 2012; 8: 439-53. pmid:22882219 PubMed
  24. Götestam Skorpen C, Lydersen S, Gilboe IM et al. Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2017; 69: 1201-08. pmid:27696790 PubMed
  25. Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity (2009) 42:257–9. DOI:10.1080/08916930902827918 DOI
  26. Buyon JP, Kim MY, Guerra MM, et al. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med 2015; 163: 153-63. pmid:26098843 PubMed
  27. Yelnik CM, Laskin CA, Porter TF et al. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 2016; 3(1): epub. pmid:26835148 PubMed
  28. Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61–73. pmid:19932376 PubMed
  29. Willis R1, Seif AM, McGwin G Jr, et al. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA, a multiethnic US cohort. Lupus 2012; 21: 830-5. pmid:22343096 PubMed
  30. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016 (Epub ahead of print). pmid:26888948 PubMed
  31. Tektonidou MG, Andreoli L, Limper M et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019. pmid:31092409 PubMed
  32. Flint J, Panchal S, Hurrell A et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016; 55: 1693-7. pmid:26750124 PubMed
  33. Flint J, Panchal S, Hurrell A et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford) 2016; 55: 1698-702. pmid:26750125 PubMed
  34. Andreoli L, Bertsias GK, Agmon-Levin N et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017; 76: 476-85. pmid:27457513 PubMed
  35. Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, et al. Healthy lifestyle habits for patients with systemic lupus erythematosus: a systemic review. Semin Arthritis Rheum. 2016 Feb;45(4):463-70. PubMed
  36. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20-8. PubMed
  37. Barsalou J, Costedoat-Chalumeau N, Berhanu A et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus. Ann Rheum Dis 2018; 77: 1742-49. pmid:30297329 PubMed
  38. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126: 76-82. pmid:22626746 PubMed
  39. Gleicher N, Elkayam U. Preventing congenital heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies. A review of published literature and registered clinical trials. Autoimmune Rev 2013;12:1039-45. PMID: 23684701 PubMed
  40. Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus. 2014 Mar;23(3):225-35. pmid:24399812 PubMed
  41. Navarra SV, Guzmán RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 721-31. PubMed
  42. Wallace DJ, Furie RA, Tanaka Y, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2018; 392: 222-31. pmid:30043749 PubMed
  43. Muangchan C, van Vollenhoven RF, Bernatsky SR, et al. Treatment algorithms in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2015. pmid:25777803 PubMed
  44. Hannah J, Casian A, D'Cruz D. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. Autoimmun Rev 2015. pmid:26427983. PubMed
  45. Metodebok.no/revmatologi: Valen M: SLE, sist oppdatert 09.02.2024, siden leste 10.04.2024 metodebok.no
  46. Tunnicliffe DJ, Palmer SC, Henderson L, et al. Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD002922. The Cochrane Library
  47. Fischer-Betz R, Specker C, Brinks R, et al. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford) 2013; 52: 1070-6. pmid:23382355 PubMed
  48. Fernandes Moça Trevisani V, Castro AA, Ferreira Neves Neto J, Atallah ÁN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD002265. DOI: 10.1002/14651858.CD002265.pub3. The Cochrane Library
  49. Stojan G, Petri M. Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol 2013; 62: 255-62. pmid:23792700 PubMed
  50. Schramm AM, Clowse ME. Aspirin for prevention of preeklampsia i lupus pregnancy. Autoimmune Dis 2014. PMID: 24778868 PubMed
  51. Fischer-Betz R, Specker C. Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol 2017; 31: 397-414. pmid:29224680 PubMed
  52. Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66: 608-16. pmid:24106157 PubMed
  53. Yafasova A, Fosbol EL, Schou M, et al. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus. J Am Coll Cardiol. 2021 Apr 13;77(14):1717-1727. PMID: 33832598 PubMed
  54. Wallenius M, Salvesen KÅ, Daltveit AK, Skomsvoll JF. SLE and outcomes in first and subsequent births. Arthritis Care Res (Hoboken) 2014; 66: 1718-24. PubMed
  55. Muangchan C, van Vollenhoven RF, Bernatsky SR, et al. Treatment algorithms in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015;67(9):1237–1245. pmid:25777803 PubMed
  56. Skomsvoll JF, Wallenius M, Salvesen KÅ, Grindheim S. Inflammatoriske revmatiske sykdommer og kollagenoser. Veileder i fødselshjelp 2019. Norsk gynekologisk forening. legeforeningen.no
  57. Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65: 913-8. pmid:16322083. PubMed
  58. Petri M, Bruce in, Dörner T, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet 2023. pmid:36848919 PubMed
  59. van Vollenhoven RF, Hahn BH, Tsokos GC, et al. Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus. Arthritis Rheumatol 2020; 72: 761-768. pmid:31769212. PubMed
  60. Levy DM. Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis. UpToDate. Last updated Jun 24, 2022. www.uptodate.com
Annonse
Annonse